Lipids in wine and beer Our group has been studying the bioactivities of lipids present in beer and wine against platelet aggregation for more than 20 years. This stream of research was spearheaded by Emeritus Professor Constantinos A Demopoulos. Under his inspirational mentoring, our group grew over the years and now we are Academics in … Continued
Some highlights of the career of Dr Ronan Lordan
Invitation to a dietary intervention study to assess the cardioprotective properties of a novel yoghurt drink.
If you are producing a food product with cardioprotective properties (e.g. kefir, cheese, yoghurt, fish, seafood), and you want to add value to your product, our team would be happy to discuss with you the possibilities of research funding towards the health-claims labeling of your product.
“Health claims” are going to be a game changer in the years to come and research data on the cardioprotective properties of your product is a safe way forward.
Antiplatelet therapies are discussed with a view to primary prevention of CVD by the clinical reduction of platelet reactivity and inflammation. Current antiplatelet therapies are effective in reducing cardiovascular risk but increase bleeding risk. Novel therapeutic antiplatelet approaches beyond current pharmacological modalities that do not increase the risk of bleeding require further investigation. There is potential for specifically designed nutraceuticals that may become safer alternatives to pharmacological antiplatelet agents for the primary prevention of CVD but there is serious concern over their efficacy and regulation, which requires considerably more research.